Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial. (2019)

First Author: Davey RT
Attributed to:  Other infectious diseases of global public health significance funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2213-2600(19)30253-x

PubMed Identifier: 31582358

Publication URI: http://europepmc.org/abstract/MED/31582358

Type: Journal Article/Review

Volume: 7

Parent Publication: The Lancet. Respiratory medicine

Issue: 11

ISSN: 2213-2600